Endogenex, in partnership with Mayo Clinic, aims to revolutionize treatment options for individuals with type 2 diabetes (T2D). Endogenex’s innovations focus on resetting the body’s metabolic signaling system by harnessing its natural regenerative capabilities to improve metabolic function. Through the development of the Endogenex System and the novel application of precise, controlled, non-thermal pulsed electric fields, Endogenex is establishing a new era in treatment options for people living with T2D, helping patients regain control of their blood glucose levels and slow disease progression.
Endogenex is a privately held, clinical-stage company based in Minneapolis, MN.
Company Details
- Employees
- 26
- Founded
- -
- Address
- 151 Cheshire Lane N,
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- https://www.endogenex.com/
- HQ
- PLYMOUTH, MN
Endogenex Questions
Endogenex's website is https://www.endogenex.com/
Endogenex's LinkedIn profile is https://www.linkedin.com/company/endogenexinc
Endogenex has
26 employees.
View email and phone details for 26
employees at Endogenex.
Endogenex's industry is
Medical Equipment Manufacturing
Endogenex's top competitors are
Sanuwave,
Venostent, Inc.,
Aurora Medical Technologies,
Paragon 28,
Averna Therapeutics,
Dragonfly Endoscopy,
Histosonics, Inc.,
Fractyl Health,
Virgo,
Nextern.
Endogenex's categories are Medical Equipment Manufacturing
Endogenex's founding year is 2017
